However, contradictory evidence indicates that in diabetic nephropathy, TFPI2 may promote endothelial-to-mesenchymal transition via TGF-β2/Smad signaling, contributing to renal fibrosis and disease progression [10]. This evidence concerns the gene TGFB2 and diabetic kidney disease.